Hostname: page-component-586b7cd67f-gb8f7 Total loading time: 0 Render date: 2024-12-02T19:50:47.719Z Has data issue: false hasContentIssue false
  • English
  • Français

Prevalence of Hepatitis C Antibodies in a Large Sample of Belgian Healthcare Workers

Published online by Cambridge University Press:  02 January 2015

Guido Moens ,
Robert Vranckx ,
Liesbeth De Greef  and
Pierre Jacques
Guido Moens*
Affiliation:
IDEWE Occupational Health Services, Leuven, Belgium Department of Occupational Medicine, the University of Leuven, Belgium
Robert Vranckx
Affiliation:
Department of Microbiology, Scientific Institute for Public Health–Louis Pasteur, Brussels, Belgium
Liesbeth De Greef
Affiliation:
IDEWE Occupational Health Services, Leuven, Belgium
Pierre Jacques
Affiliation:
IDEWE Occupational Health Services, Leuven, Belgium Department of Occupational Medicine, the University of Leuven, Belgium
*
Interleuvenlaan 58, B-3001 Leuven, Belgium
Get access Rights & Permissions [Opens in a new window]

Abstract

Objective:

To assess the risk of hepatitis C virus (HCV) infection among Belgian (Flemish) healthcare workers.

Design:

A seroprevalence survey of HCV IgG antibodies.

Setting and Participants:

A systematic sample of 5,064 employees from 22 general hospitals in Flanders and Brussels, Belgium, was tested at the annual occupational medical examination. Together with demographic and occupational data, information was collected on the frequency of blood contact, needlestick injuries, and medical and surgical history. The blood samples were tested using the third-generation Abbott Screen Kit test, with confirmation by Matrix, LIA, and an in-house polymerase chain reaction and the Quantiplex-HCV b-DNA test.

Results:

21 persons were found to be positive for HCV markers. The overall prevalence was 0.41% (95% confidence interval [CI95], 0.24-0.59). A statistically significant association was found with a history of blood transfusion (odds ratio [OR], 4.14; CI95, 1.67-10.31) and with history of a clinically apparent hepatitis (OR, 3.98; CI95,1.60-9.90). Although the ORs for the frequency of blood contact were slightly elevated (between 1.17 and 2.73), this association was not significant. Moreover, a history of needlestick injuries showed a nonsignificant OR of 1.28 (CI95, 0.53-3.09), and no statistically significant difference was found with a variety of duties and tasks. The ORs for potential occupational risk factors were adjusted according to age, gender, antecedents, and other confounders using a logistic regression analysis. Based on this procedure, the ORs decreased slightly.

Conclusions:

Flemish healthcare workers showed a lower HCV seropositivity than is seen in the general population; a history of blood transfusion and of clinically apparent hepatitis was most strongly associated with the presence of HCV markers. We concluded that employees in Flemish regional general hospitals are not at an overall increased risk for HCV infection, although occasional transmission through percutaneous injuries is possible, and prevention therefore remains imperative.

Type
Original Articles
Information
Infection Control & Hospital Epidemiology , Volume 21 , Issue 3 , March 2000 , pp. 209 - 212
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2000

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Gerberding, JL. Management of occupational exposures to blood-borne viruses. N Engl J Med 1996;332:444–451.CrossRefGoogle Scholar
2.MacDonald, M, Crofts, N, Kaldor, J. Transmission of hepatitis C virus: rates, routes, and cofactors. Epidemiol Rev 1996;18:137–148.CrossRefGoogle ScholarPubMed
3.Klein, RS, Freeman, K, Taylor, PE, Stevens, CE. Occupational risk for hepatitis C virus infection among New York City dentists. Lancet 1991;338:1539–1542.CrossRefGoogle ScholarPubMed
4.Libanore, M, Bicocchi, R, Ghinelli, F, Palumbo, G, Moretti, M, Pazzi, P, et al. Prevalence of antibodies to hepatitis C virus in Italian health care workers. Infection 1992;20:54.CrossRefGoogle ScholarPubMed
5.Sirchia, G, Almini, D, Bellobuono, A, Giovanetti, AM, Marconi, M, Mercuriali, F, et al. Prevalence of hepatitis C virus antibodies in Italian blood donors. The Italian Cooperative Group. Vox Sang 1990;59:26–29.CrossRefGoogle ScholarPubMed
6.Polish, LB, Tong, MJ, Co, RL, Coleman, PJ, Alter, MJ. Risk factors for hepatitis C virus infection among health care personnel in a community hospital. Am J Infect Control 1993;21:196–200.CrossRefGoogle Scholar
7.Beutels, M, Van Damme, P, Aelvoet, W, Desmyter, J, Dondeyne, F, Goilav, C, et al. Prevalence of hepatitis A, B and C in the Flemish population. Eur J Epidemiol 1997;13:275–280.CrossRefGoogle Scholar
8.Letaïef, H. Hepatite C en Belgique: Seroprevalence et Facteurs de Risque. Antwerp, Belgium: Institute for Tropical Medicine; 1995. Dissertation.Google Scholar
9.Vranckx, R, Muylle, L. Prevalence of antibodies to hepatitis viruses in blood donors with a clinical history of hepatitis. Zentralbl Bakteriol 1992;276:540–547.CrossRefGoogle ScholarPubMed
10.Cooper, BW, Krusell, A, Tilton, RC, Goodwin, R, Levitz, RE. Seroprevalence of antibodies to hepatitis C virus in high-risk hospital personnel. Infect Control Hosp Epidemiol 1992;13:82–85.CrossRefGoogle ScholarPubMed
11.Kleinbaum, D, Kupper, L, Morgenstern, H. Epidemiologic Research: Principles and Quantitative Methods. New York, NY: Van Nostrand Reinhold; 1982.Google Scholar
12.Kahn, HA, Sempos, CT. Statistical Methods in Epidemiology. New York, NY: Oxford University Press; 1989.Google Scholar
13.Ministry of Public Health. Statistics of health care institutions. Brussels, Belgium: Administration of the Health Care Institutions; 1990.Google Scholar
14.De Brouwer, C, Liesnard, C, Bourgeois, N, Lecomte, A. L'hépatite, C, estce une maladie professionnelle? Cahiers Méd Travail 1996;33:159–171.Google Scholar
15.Kühnl, P, Seidl, S, Stangel, W, Beyer, J, Sibrowski, W, Flik, J. Antibody to hepatitis C virus in German blood donors. Lancet 1989;2:324.CrossRefGoogle ScholarPubMed
16.Bar-Shany, S, Green, MS, Shinar, E. False positive tests for anti-hepatitis C antibodies and the problem of notifying blood donors. Int J Epidemiol 1996;25:674–678.CrossRefGoogle ScholarPubMed
17.Bonanni, P, Icardi, GC, Raffo, AM, Ferrari Bravo, M, Roccatagliata, A, Crovari, P. Analytical and laboratory evaluation of new fully-automated third generation enzyme immunoassay for the detection of antibodies to the hepatitis C virus. J Virol Methods 1996;62:113–122.CrossRefGoogle ScholarPubMed
18.Uyttendaele, S, Claeys, H, Mertens, W, Verhaert, H, Vermylen, C. Evaluation of third-generation screening and confirmatory assays for HCV antibodies. Vox Sang 1994;66:122–129.Google ScholarPubMed
19.Checkoway, H, Pearce, N, Crawford-Brown, DJ. Research Methods in Occupational Epidemiology. New York, NY: Oxford University Press; 1989.Google ScholarPubMed